Regional cooling of the extracorporeal blood circuit: a novel anticoagulation approach for renal replacement therapy?
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- akutní poškození ledvin MeSH
- hemofiltrace metody MeSH
- mimotělní oběh metody MeSH
- modely nemocí na zvířatech MeSH
- prasata MeSH
- renální insuficience terapie MeSH
- terapeutická hypotermie * MeSH
- trombocytóza prevence a kontrola MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVE: To test the hypothesis that cooling of blood in the extracorporeal circuit of continuous veno-venous hemofiltration (CVVH) enables to realize the procedure without the need of anticoagulation. DESIGN: Experimental animal study. METHODS: We developed the device for selective cooling of extracorporeal circuit (20 degrees C) allowing blood rewarming (38 degrees C) just before returning into the body. Twelve anesthetized and ventilated pigs were randomized to receive either 6 h of CVVH with application of this device (COOL; n = 6) or without it (CONTR; n = 6). MEASUREMENTS: Before the procedure and in 15, 60, 180, 360 min after starting hemofiltration variables related to: (1) circuit patency [time to clotting (TC), number of alarm-triggered pump stopping (AS), venous and transmembranous circuit pressures (VP, TMP)], (2) coagulation status in the extracorporeal circuit [thrombin-antithrombin complexes (TAT(circ)), thromboelastography (TEG)] and (3) animal status (hemodynamics, hemolysis and biochemistry) were assessed. RESULTS: The patency of all circuits treated with selective cooling was well maintained within the observation period. By contrast, five of six sessions were prematurely clotted in the untreated group. As a result, the number of AS was significantly higher in the CONTR group. In-circuit thrombus generation in CONTR group was associated with a markedly increasing TAT(circ). TEG performed at 180 min of the procedure revealed a tendency to a prolonged initial clotting time and a significant decrease in clotting rate of in-circuit blood in the COOL group. No signs of repeated cooling/rewarming-induced hemolysis were observed in animals treated with "hypothermic circuit" CVVH. CONCLUSION: In this porcine model, regional extracorporeal blood cooling proved effective in preventing in-circuit clotting without the need to use any other anticoagulant.
Zobrazit více v PubMed
J Trauma. 2005 May;58(5):1002-9; discussion 1009-10 PubMed
Crit Care. 2007;11(4):218 PubMed
Anesth Analg. 2003 Jun;96(6):1772-6, table of contents PubMed
Ann Surg. 1987 Feb;205(2):175-81 PubMed
Metabolism. 2007 Feb;56(2):214-21 PubMed
Crit Care Med. 1992 Oct;20(10):1402-5 PubMed
Intensive Care Med. 2000 Nov;26(11):1652-7 PubMed
Crit Care Clin. 2004 Jan;20(1):13-24 PubMed
Resuscitation. 2001 Oct;51(1):83-90 PubMed
J Trauma. 1998 May;44(5):846-54 PubMed
J Trauma. 1994 May;36(5):634-8 PubMed
J Trauma. 2004 Jun;56(6):1221-8 PubMed
Blood. 1999 Jul 1;94(1):199-207 PubMed
Thromb Res. 2006;117(5):597-602 PubMed
Blood Purif. 1997;15(3):200-7 PubMed
Intensive Care Med. 2006 Feb;32(2):188-202 PubMed